Sungening Biological Co., Ltd. is a clinical need-driven innovative drug developer specializing in AI-enabled cyclic peptide therapeutics. The company focuses on high-value therapeutic areas including anti-infection and metabolic diseases. Leveraging mRNA display technology, AI-driven cyclic peptide molecular simulation, and proprietary technologies for cyclic peptide druggability optimization. The company has built a well-tiered pipeline of R&D candidates. Its lead candidate has completed dual IND filings in China and the U.S. and is advancing steadily into global clinical development. We are dedicated to delivering more precise and safer therapeutic solutions to patients worldwide.